Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment
Sponsor: M.D. Anderson Cancer Center
Terminated
\<75% participation
Other terminated trials from M.D. Anderson Cancer Center
A observational or N/A phase clinical study on Breast Cancer Survivor and Pregnant Women, this trial is terminated or withdrawn. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 3 data snapshots since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Study Description(click to expand)Primary Objectives Provide preliminary data to describe the current QOL of breast cancer survivors who received cancer treatment while pregnant.
Secondary Objectives Identify the relationship between QOL and anxiety, depression, fear of cancer recurrence, and social support in breast cancer survivors, who received treatment while pregnant.
Primary Objectives Provide preliminary data to describe the current QOL of breast cancer survivors who received cancer treatment while pregnant.
Secondary Objectives Identify the relationship between QOL and anxiety, depression, fear of cancer recurrence, and social support in breast cancer survivors, who received treatment while pregnant.
Status Flow
Change History
3 versions recorded-
Apr 18, 2026 — Present [daily]
Terminated
Status: Recruiting → Terminated
-
Apr 16, 2026 — Apr 18, 2026 [daily]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2025 — Apr 2026 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
To assess the quality of life for women who were pregnant during their breast cancer treatment.
Contact Information
- M.D. Anderson Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .